Search results for "DRUG DELIVERY SYSTEMS"

showing 10 items of 304 documents

Montmorillonite nanodevices for the colon metronidazole delivery.

2013

The adsorption profiles of the antibiotic metronidazole (MNE) into the K10-montmorillonite (MMT-K10) clay and the subsequent release have been investigated as a function of pH and MNE/MMT-K10 ratio, in order to evaluate the potential of the MNE/MMT-K10 hybrids as controlled drug delivery system. The adsorption mechanism has been first elucidated by performing complementary equilibrium and kinetic studies and through the X-ray diffractometry (XRD) characterization of the obtained composite materials. The gathered results allowed us to propose a mechanism consisting of a multi-step pathway involving the neutral and the cationic form of the drug, which interact with different sites of the clay…

DrugColonmedia_common.quotation_subjectPharmaceutical ScienceDrug release kineticschemistry.chemical_compoundAdsorptionDrug Delivery SystemsMetronidazolemedicineOrganic chemistrymedia_commonSettore CHIM/02 - Chimica FisicaK10-montmorillonite metronidazole adsorption drug deliverySettore GEO/06 - MineralogiaCationic polymerizationAnti-Bacterial AgentsNanostructuresMetronidazoleMontmorillonitechemistryChemical engineeringSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryBentoniteOral retinoidmedicine.drugInternational journal of pharmaceutics
researchProduct

In-situ forming gel-like depot of a polyaspartamide-polylactide copolymer for once a week administration of Sulpiride

2015

Abstract Objectives An in-situ forming gel-like depot, prepared by using an appropriate polyaspartamide-polylactide graft copolymer, has been employed to release in a sustained way sulpiride. Methods α,β-poly(N-2-hydroxyethyl)-D,L-aspartamide-g-polylactic acid (PHEA-g-PLA) has been used as a polymer component. Its physicochemical properties make possible to dissolve it in N-methyl-2-pyrrolidone, with the obtainment of a solution able to form a gel-like depot once injected into a physiological medium. Cell compatibility of PHEA-g-PLA depot has been investigated, using murine dermal fibroblasts as cell model. 3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazo…

DrugDepotPolymersmedia_common.quotation_subjectChemistry PharmaceuticalPolyesterssulpiridePharmaceutical SciencePharmacologyCell Linechemistry.chemical_compoundDrug Delivery SystemsPharmacokineticsPolylactic acidmedicineFluorescence microscopeCopolymerAnimalsViability assayRats Wistarpolylactic acidgraft copolymermedia_commonPharmacologyin-situ forming depotRatsDrug LiberationchemistryRabbitsSulpiridePeptidesαβ-poly(N-2-hydroxyethyl)-DL-aspartamidemedicine.drug
researchProduct

Aloin delivery on buccal mucosa: ex vivo studies and design of a new locoregional dosing system

2014

Context: Chemoprevention of potential malignant disorders or cancerous lesions that affect oral mucosae requires extended duration of treatment. Locoregional delivery of natural products could represent a promising strategy for this purpose. Objective: To investigate the aptitude of aloin to permeate through, or accumulate in, the buccal mucosa and to develop a new prolonged oro-mucosal drug delivery system. Materials and Methods: Permeation/accumulation of aloin from Curacao Aloe (containing 50% barbaloin) was evaluated ex vivo, using porcine buccal mucosa as the most useful model to simulate human epithelium. Oro-mucosal matrix tablets were prepared by dispersing aloin (10% w/w) in Eudrag…

DrugEmodinPolymersSwinemedia_common.quotation_subjectChemistry PharmaceuticalAcrylic ResinsPharmaceutical ScienceDentistryAloinPharmacologyFriabilityPermeabilityBarbaloin buccal tablets aloin matrix tablets oro-mucosal delivery locoregional drug delivery buccal mucosa.chemistry.chemical_compoundDrug Delivery SystemsSettore MED/28 - Malattie OdontostomatologicheDrug DiscoverymedicineAnimalsDosingAloemedia_commonPharmacologybusiness.industryOrganic ChemistryMouth MucosaAdhesivenessReproducibility of ResultsPermeationDrug LiberationchemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliverySwellingmedicine.symptombusinessEx vivoTablets
researchProduct

Potential transbuccal delivery of l-DOPA methylester prodrug: stability in the environment of the oral cavity and ability to cross the mucosal tissue

2016

Levodopa (l-DOPA) is the most effective pharmacologic agent in Parkinson's disease and remains the "gold standard". Nevertheless, in long-term treatments, dyskinesias and motor complications can emerge. In this work, the combined use of l-DOPA methylester hydrochloride prodrug (LDME) with transbuccal drug delivery was supposed as a good alternative method to optimize the bioavailability of l-DOPA, to maintain constant plasma levels and to decrease the drug unwanted effects. The effects of environmental pH on buccal delivery of LDME were evaluated ex vivo. The increase of pH value from 5.8 to 6.2 implies an improvement of drug permeation. Since the pH increase causes the raising of hydrolyti…

DrugHydrochloridemedia_common.quotation_subjectPharmaceutical Science02 engineering and technologyPharmacologyAntiparkinson AgentsLevodopachemical stability03 medical and health scienceschemistry.chemical_compoundDrug Delivery Systems0302 clinical medicineDrug StabilitySettore MED/28 - Malattie OdontostomatologicheProdrugsmedia_commonBuccal permeationMouthintellidrug deviceMouth MucosaParkinson DiseaseGeneral MedicineBuccal administrationPermeationProdrug021001 nanoscience & nanotechnologytransmucosal drug deliveryBioavailabilitychemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryprodrug0210 nano-technology030217 neurology & neurosurgeryEx vivo
researchProduct

PLGA nanoparticles are effective to control the colonic release and absorption on ibuprofen.

2018

The oral controlled release (CR) formulations have become more important in recent years. Among them, the polymeric nanoparticles have been thoroughly studied during the last decades, consequently they are extensively employed for a broad range of applications and drugs. The objective of this research was to develop polymeric nanoparticles (NPs) of ibuprofen with poly(lactic-co-glycolic) acid (PLGA) as polymer, and to test their applicability for oral CR formulations development. Different proportions of drug/polymer were employed to develop the ibuprofen NPs and their in vitro release profiles were analysed. The in situ segmental permeability of ibuprofen was tested in Wistar rat and demon…

DrugMaleColonPolymersmedia_common.quotation_subjectPharmaceutical ScienceIbuprofen02 engineering and technologyAbsorption (skin)030226 pharmacology & pharmacyPermeability03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDrug Delivery SystemsPolylactic Acid-Polyglycolic Acid CopolymerIn vivomedicineAnimalsLactic AcidRats Wistarmedia_commonchemistry.chemical_classificationDrug CarriersChromatographyorganic chemicalstechnology industry and agriculturePolymer021001 nanoscience & nanotechnologyIbuprofenControlled releaseRatsPLGAchemistryIntestinal AbsorptionPermeability (electromagnetism)Delayed-Action PreparationsNanoparticles0210 nano-technologyPolyglycolic Acidmedicine.drugEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Polybenzofulvene derivatives bearing dynamic binding sites as potential anticancer drug delivery systems.

2020

In order to obtain new advanced functional materials capable of recognizing drug molecules, the polybenzofulvene backbone of molecular brush poly-6-MOEG-9-TM-BF3k has been functionalized with a “synthetic dynamic receptor” composed of two 1-adamantylurea moieties linked together by means of a dipropyleneamino bridge as in Meijer's bis(adamantylurea) pincer (BAUP). This functional material, bearing synthetic receptors potentially capable of recognizing/loading and then delivering drug molecules, was used to prepare colloidal drug delivery systems (by means of soft interaction with BAUP) for delivering the model anti-cancer drug doxorubicin (DOXO). The resulting nanostructured drug delivery s…

DrugMaterials scienceStereochemistrymedia_common.quotation_subjectBiomedical EngineeringGeneral ChemistryGeneral MedicinePolybenzofulvene drug delivery systems DoxorubicinIn vitroCancer cellDrug deliveryZeta potentialmedicineFluorescence microscopeBiophysicsGeneral Materials ScienceDoxorubicinCytotoxicitymedicine.drugmedia_commonJournal of materials chemistry. B
researchProduct

Antibacterial drug release from a biphasic gel system: Mathematical modelling

2019

Bacterial infections represent an important drawback in the orthopaedic field, as they can develop either immediately after surgery procedures or after some years. Specifically, in case of implants, they are alleged to be troublesome as their elimination often compels a surgical removal of the infected implant. A possible solution strategy could involve a local coating of the implant by an antibacterial system, which requires to be easily applicable, biocompatible and able to provide the desired release kinetics for the selected antibacterial drug. Thus, this work focusses on a biphasic system made up by a thermo-reversible gel matrix (Poloxamer 407/water system) hosting a dispersed phase (…

DrugMaterials sciencemedia_common.quotation_subjectVancomycin HydrochloridePharmaceutical SciencePoloxamer02 engineering and technologyantibacterial drugengineering.material030226 pharmacology & pharmacyDiffusion03 medical and health scienceschemistry.chemical_compoundDrug Delivery Systems0302 clinical medicineMicro-particleCoatingVancomycinAntibacterial drugmedicineAntibacterial drugmedia_commonGelMathematical modellingReproducibility of ResultsMicro-particlesModels Theoretical021001 nanoscience & nanotechnologyAnti-Bacterial AgentsDrug LiberationKineticsPLGAchemistrySettore CHIM/09 - Farmaceutico Tecnologico Applicativoantibacterial drug; Gels; Mathematical modelling; Micro-particles; Orthopaedic implantsPoloxamer 407engineeringOrthopaedic implantsDelivery systemImplant0210 nano-technologyGelsmedicine.drugBiomedical engineeringInternational Journal of Pharmaceutics
researchProduct

Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19

2021

The SARS-CoV-2 virus is causing devastating morbidity and mortality worldwide. Nanomedicine approaches have a high potential to enhance conventional diagnostics, drugs and vaccines. In fact, lipid nanoparticle/mRNA vaccines are already widely used to protect from COVID-19. In this review, we present an overview of the taxonomy, structure, variants of concern, epidemiology, pathophysiology and detection methods of SARS-CoV-2. The efforts of repurposing, tailoring, and adapting pre-existing medications to battle COVID-19 and the state of vaccine developments are presented. Next, we discuss the broad concepts and limitations of how nanomedicine could address the COVID-19 threat. Nanomaterials …

DrugMedicine (General)Coronavirus disease 2019 (COVID-19)nanotechnologyComputer scienceSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)media_common.quotation_subjectDiagnostic testNanotechnologySARS-CoV-2 virusReviewGeneral Medicineacute respiratory distress syndromesepsisdrug delivery systemsR5-920vaccineMedicineNanomedicineInorganic materialsRepurposingmedia_commonAir filterFrontiers in Medicine
researchProduct

Influence of drug polarity upon the solid-state structure and release properties of self-emulsifying drug delivery systems in relation with water aff…

2009

To overcome low oral bioavailability of poorly water-soluble drugs, self-emulsifying drug delivery systems (SEDDS) have been noted as a promising strategy. However, incorporation of drugs into SEDDS composed of Gelucire44/14 could induce interactions not yet well understood. The aim of this study was to investigate the influence of drug polarity upon the solid-state structure of SEDDS formulation, particularly in terms of wettability, thermal behaviour and microscopic aspects and their effect upon the release properties of the SEDDS. Model drugs were naproxen and sodium naproxen (10% w/w), two drugs with similar chemical structure but different water solubilities. Both drugs had an effect o…

DrugNaproxenmedia_common.quotation_subjectChemical structureNaproxen SodiumSolid state structurePolyethylene GlycolsColloid and Surface ChemistryDrug Delivery SystemsmedicinePhysical and Theoretical ChemistrySolubilitymedia_commonChromatographyCalorimetry Differential ScanningChemistryWaterSurfaces and InterfacesGeneral MedicineBioavailabilityKineticsChemical engineeringEmulsifying AgentsDrug deliveryMicroscopy Electron ScanningHydrophobic and Hydrophilic InteractionsBiotechnologymedicine.drugColloids and surfaces. B, Biointerfaces
researchProduct

Solid lipid nanoparticles containing tamoxifen characterization and in vitro antitumoral activity.

2005

Solid lipid nanoparticles (SLNs) containing tamoxifen, a nons- teroidal antiestrogen used in breast cancer therapy, were prepared by microemulsion and precipitation techniques. Tamoxifen loaded SLNs seem to have dimensional properties useful for parenteral administration, and in vitro plasmatic drug release studies demon- strated that these systems are able to give a prolonged release of the drug in the intact form. Preliminary study of antiproliferative ac- tivity in vitro, carried out on MCF-7 cell line (human breast cancer cells), demonstrated that SLNs, containing tamoxifen showed an antitumoral activity comparable to free drug. The results of char- acterization studies and of in vitro …

DrugOctanolsMaterials scienceTime FactorsAntineoplastic Agents Hormonalmedia_common.quotation_subjectPharmaceutical SciencePharmacologyColloidal Drug Delivery Systems Solid Lipid Nanoparticles (SLNs) TamoxifenBreast cancerDrug StabilityCell Line TumorSolid lipid nanoparticlemedicineHumansParticle Sizeskin and connective tissue diseasesmedia_commonCell ProliferationDrug CarriersWaterGeneral MedicineHydrogen-Ion Concentrationmedicine.diseaseAntiestrogenLipidsIn vitroNanostructuresbody regionsTamoxifenSolubilityDelayed-Action PreparationsCancer cellDrug carrierTamoxifenmedicine.drugDrug delivery
researchProduct